- Home
- VERO vs XBIO Comparison
VERO vs XBIO Comparison
Compare VERO & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- XBIO
- Stock Information
- Founded
- VERO N/A
- XBIO N/A
- Country
- VERO Canada
- XBIO United States
- Employees
- VERO N/A
- XBIO N/A
- Industry
- VERO Medical/Dental Instruments
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- VERO Health Care
- XBIO Health Care
- Exchange
- VERO Nasdaq
- XBIO Nasdaq
- Market Cap
- VERO 4.6M
- XBIO 4.2M
- IPO Year
- VERO N/A
- XBIO N/A
- Fundamental
- Price
- VERO $2.19
- XBIO $3.53
- Analyst Decision
- VERO
- XBIO Hold
- Analyst Count
- VERO 0
- XBIO 1
- Target Price
- VERO N/A
- XBIO N/A
- AVG Volume (30 Days)
- VERO 3.3M
- XBIO 169.6K
- Earning Date
- VERO 08-12-2025
- XBIO 08-12-2025
- Dividend Yield
- VERO N/A
- XBIO N/A
- EPS Growth
- VERO N/A
- XBIO N/A
- EPS
- VERO N/A
- XBIO N/A
- Revenue
- VERO $60,997,000.00
- XBIO $2,582,728.00
- Revenue This Year
- VERO N/A
- XBIO $14.23
- Revenue Next Year
- VERO $7.47
- XBIO $7.14
- P/E Ratio
- VERO N/A
- XBIO N/A
- Revenue Growth
- VERO N/A
- XBIO 5.63
- 52 Week Low
- VERO $2.10
- XBIO $2.20
- 52 Week High
- VERO $14.50
- XBIO $5.27
- Technical
- Relative Strength Index (RSI)
- VERO 41.93
- XBIO 58.63
- Support Level
- VERO $2.15
- XBIO $2.65
- Resistance Level
- VERO $4.25
- XBIO $5.27
- Average True Range (ATR)
- VERO 0.33
- XBIO 0.45
- MACD
- VERO -0.03
- XBIO 0.09
- Stochastic Oscillator
- VERO 2.38
- XBIO 33.61
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.